Monoclonal antibody (mAb) manufacturing must continually improve to keep up with increasing demands. To do this, biomanufacturers can deploy machine learning tools to augment traditional process ...
At a time when large-scale human genome analysis was not yet common, the Tohoku Medical Megabank Organization (ToMMo) launched its genome cohort study. After 10 years of operating this ambitious ...
Operating massive reverse proxy fleets reveals hard lessons: optimizations that work on smaller systems fail at scale; mundane oversights like missing commas cause major outages; and abstractions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results